# Shah‐Jalal Sarker

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/shah-jalal-sarker/

## Facts

| Field | Value |
| --- | --- |
| Citations | 1,798 |
| Field | Renal cell carcinoma treatment |
| h-index | 20 |
| i10-index | 28 |
| Last Known Institution | Queen Mary University of London |
| OpenAlex ID | https://openalex.org/A5008920583 |
| ORCID iD | 0000-0003-0254-432X |
| Works | 77 |

## Researcher papers

- [Capivasertib Plus Paclitaxel Versus Placebo Plus Paclitaxel As First-Line Therapy for Metastatic Triple-Negative Breast Cancer: The PAKT Trial](https://scholariq.org/papers/capivasertib-plus-paclitaxel-versus-placebo-plus-paclitaxel-as-first-line/)
- [A Randomized Prospective Study Comparing Acquisition of Laparoscopic Skills in Three‐Dimensional (3D) vs. Two‐Dimensional (2D) Laparoscopy](https://scholariq.org/papers/a-randomized-prospective-study-comparing-acquisition-of-laparoscopic-skills-in/)
- [A Randomised Phase 2 Study of AZD2014 Versus Everolimus in Patients with VEGF-Refractory Metastatic Clear Cell Renal Cancer](https://scholariq.org/papers/a-randomised-phase-2-study-of-azd2014-versus-everolimus-in-patients-with-vegf/)
- [Obesity and diabetes are major risk factors for epicardial adipose tissue inflammation](https://scholariq.org/papers/obesity-and-diabetes-are-major-risk-factors-for-epicardial-adipose-tissue/)
- [A phase II study investigating the safety and efficacy of neoadjuvant atezolizumab in muscle invasive bladder cancer (ABACUS).](https://scholariq.org/papers/a-phase-ii-study-investigating-the-safety-and-efficacy-of-neoadjuvant/)
- [Fulvestrant Plus Vistusertib vs Fulvestrant Plus Everolimus vs Fulvestrant Alone for Women With Hormone Receptor–Positive Metastatic Breast Cancer](https://scholariq.org/papers/fulvestrant-plus-vistusertib-vs-fulvestrant-plus-everolimus-vs-fulvestrant-alone/)
- [Safety and Efficacy of Pazopanib Therapy Prior to Planned Nephrectomy in Metastatic Clear Cell Renal Cancer](https://scholariq.org/papers/safety-and-efficacy-of-pazopanib-therapy-prior-to-planned-nephrectomy-in/)
- [Fertility and sexual function in long‐term survivors of haematological malignancy: using patient‐reported outcome measures to assess a neglected area of need in the late effects clinic](https://scholariq.org/papers/fertility-and-sexual-function-in-long-term-survivors-of-haematological/)
- [A multicentre retrospective cohort study of ovarian germ cell tumours: Evidence for chemotherapy de-escalation and alignment of paediatric and adult practice](https://scholariq.org/papers/a-multicentre-retrospective-cohort-study-of-ovarian-germ-cell-tumours-evidence/)
- [Impact of the new UK licensing law on emergency hospital attendances: a cohort study](https://scholariq.org/papers/impact-of-the-new-uk-licensing-law-on-emergency-hospital-attendances-a-cohort/)
- [Objective Assessment of Skills Acquisition During Laparoscopic Surgery Courses](https://scholariq.org/papers/objective-assessment-of-skills-acquisition-during-laparoscopic-surgery-courses/)

## Researcher topics

- [Renal cell carcinoma treatment](https://scholariq.org/topics/renal-cell-carcinoma-treatment/)
- [Testicular diseases and treatments](https://scholariq.org/topics/testicular-diseases-and-treatments/)
- [Radiomics and Machine Learning in Medical Imaging](https://scholariq.org/topics/radiomics-and-machine-learning-in-medical-imaging/)
- [Ovarian cancer diagnosis and treatment](https://scholariq.org/topics/ovarian-cancer-diagnosis-and-treatment/)
- [Childhood Cancer Survivors' Quality of Life](https://scholariq.org/topics/childhood-cancer-survivors-quality-of-life/)

## Researcher university

- [Queen Mary University of London](https://scholariq.org/institutions/queen-mary-university-of-london/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.